|
|
 |
|
Viewing report
|
|
|
|
PET/CT and SPECT/CT To Plan and Monitor the Treatment of Cancer
CME Group, Nov 2006
The precise tailoring of treatment for patients with cancer is an unmet challenge. The goal is to only administer treatments that have a high probability of being effective. Imaging with PET/CT and SPECT/CT provides methods that will help achieve this goal. The program covers the current clinical challenges, the new emerging answers from imaging, and how these methods can be applied to patient care.
Short descriptions of the fundamentals of maximizing the performance of these procedures are presented and a greater emphasis is put on interpretation of the studies. Johns Hopkins physicians and visiting experts describe how to use PET/CT and SPECT/CT to help solve the problems encountered when treating patients, and nuclear medicine physicians with extensive experience using these techniques give insight into how best to tailor the studies for patients with various types of cancer.
Learning Objectives
After viewing this program, participants should be able to:
- Be familiar with the basic techniques used to perform a PET/CT or SPECT/CT study and the steps necessary to perform several studies on the same patient and obtain useful quantitative response data
- Gain perspective about which patients benefit the most from these studies to assess response to treatment
- Learn how Johns Hopkins physicians are using PET/CT and SPECT/CT studies to meet the challenges faced when treating patients
- Understand how this field is rapidly developing and gain insight into the exciting areas that lie ahead
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Faculty Disclosure
It is the policy of The Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the course handout materials.
Customers who bought this item also bought
Personalized Medicine - Scientific and Commercial Aspects
Nuclear Oncology
Drug Delivery in Cancer - Technologies, Markets and Companies
Global Nuclear Medicine Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 – 2015)
Hematology and Medical Oncology Best Practices
Innovations in Oncology Diagnostics: Technological Advances, Growth Opportunities and Future Market Outlook
Nuclear Cardiology Markets
Radiology, Nuclear Medicine, Radiation Therapy, 2nd Edition
Mammography World Markets
Cardiovascular Medicine: Review and Update for the Practitioner
|
|
|
|
